Therapy-Resistant Residual Cancer Cell Dependencies Mapped

Cancer drugs can shrink fast-growing tumors. But sometimes a few tumor cells survive. These “persister” cells seed new tumors, forcing cancer patients into arduous cycles of testing and treatment. The problem is that persister cells are rare—as few as one in a thousand tumor cells—and they’re genetically identical to the tumor, which makes them hard to find. Plus, their tenacity can be temporary, and by the time a scientist can get them in a petri dish, the qualities that helped them survive may have faded.

The Every Company Boosts Animal-Free Egg Capacity with Huvepharma After 550% Hike in Orders

With its recombinant egg white protein already featuring in products stocked at Walmart, Target and Amazon, interest in The Every Company’s precision-fermented ingredient is soaring.

French Plant-Based Meat Startup Swap Food Enters Liquidation, Faces Shutdown Without Buyer

A year after replacing its CEO amid financial struggles, French startup Swap Food – best known for its whole-cut vegan chicken – has fallen into insolvency.

World Food Safety Day / Honduras Celebrates With Academia

June 2026, US: This year the Codex Contact Point in Honduras celebrated with academia. Every university in Tegucigalpa t…

Inside LVMH’s beauty shakeup amid luxury slowdown

LVMH is seemingly trying to cushion the blow of luxury beauty’s slowdown, driven by economic pressures and weakening consumer spending. The group’s business moves, and those adjacent, signal a reshuffle of its beauty portfolio as it hunts for growth in a cooling market. 

Five Alternative Protein Companies Named in TIME’s World’s Top GreenTech Ranking

Five companies from the alternative protein sector have been included in TIME magazine’s second annual World’s Top GreenTech Companies list, published in partnership with data firm Statista. The 250-company ranking covers businesses across sectors, including renewable energy, carbon capture, mobility, and food technology, evaluated on environmental impact, financial strength, and innovation.

India’s US$30 billion beauty boom grows online, bringing new opportunities and risks

India’s beauty and personal care market has surpassed US$30 billion, fueled by rising incomes, urbanization, and the boom of e-commerce and quick commerce. However, as the country’s cosmetic trade increasingly moves online, safety concerns are arising about whether oversight can keep pace. 

Seprify: “Reformulating Away From Titanium Dioxide Is No Longer a Future Consideration but an Immediate Requirement”

As food manufacturers across Europe scramble to reformulate products following the EU ban on titanium dioxide, Swiss biomaterials company Seprify has developed a plant-based alternative derived from FSC-certified wood pulp. The Marly-based startup, which spun out of the University of Cambridge and the University of Fribourg, produces cellulose-based white pigments designed to replicate the opacity and brightness that titanium dioxide has long provided in food applications. The company recently closed a €13.4 million Series A round and has partnered with natural colour supplier Oterra to bring the ingredient to food and beverage manufacturers globally.

谁能定义未来农业的″操作系统″?透视巴西狂飙的生物时代与中国的抉择

在全球农业迈向可持续转型的浪潮中,生物投入品正从边缘补充角色跃升为战略核心。而在这场变革中,巴西无疑是最耀眼的舞台。作为全球增长最快的农用生物制剂市场之一,巴西不仅在应用规模上领先,更在技术、制度与产业生态层面形成了独特的″热带创新模式″。…

Silica Nanoparticles Induce Ferroptosis, Reprogram Immunity in Prostate Cancer Models

Ultrasmall fluorescent core‑shell silica nanoparticles—best known for their roles in medical imaging applications —are now showing surprising therapeutic muscle. Originally engineered as inert carriers for imaging agents, these particles, called Cornell Prime dots (C’ dots), have steadily expanded their résumé. In a new preclinical study, researchers at Weill Cornell Medicine report that these engineered silica nanoparticles can directly kill prostate tumor cells while reawakening antitumor immunity , offering a potential new edge in a disease where immunotherapy has historically struggled.